Brilliance 2025 – In-Person Celebration of Women Disrupting Healthcare
Brilliance 2025 - themed "Celebrating Women Disrupting Healthcare" - brings together executives, physicians, and entrepreneurs to share bold strategies for...
Brilliance 2025 - themed "Celebrating Women Disrupting Healthcare" - brings together executives, physicians, and entrepreneurs to share bold strategies for...
NORTHAMPTON, MA / ACCESS Newswire / October 23, 2025 / Niko Kotsaftis, Energy & Sustainability Program Manager at MilliporeSigma, the...
NEWARK, DELAWARE / ACCESS Newswire / October 23, 2025 / MedCognetics, a pioneer in artificial intelligence (AI) for breast cancer...
SALT LAKE CITY, UT / ACCESS Newswire / October 23, 2025 / Utah Medical Products, Inc. (NASDAQ:UTMD) reports third quarter...
NAPLES, FL / ACCESS Newswire / October 23, 2025 / "STEMTECH CORPORATION", the global leader and pioneer in stem cell...
SAN JOSE, CALIFORNIA / ACCESS Newswire / October 23, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a pioneering force in telehealth...
With the industry's largest network of sites, Florence sets a new benchmark for AI-enabled study startup, workflow automation, and operational...
New findings highlight Telomir-1's impact on CASP8 and GSTP1, two critical genes that regulate cell death and glutathione-based detoxification pathways...
CAMBRIDGE, MA / ACCESS Newswire / October 23, 2025 / Moderna, Inc. (Nasdaq:MRNA) today announced that it will host its...
Combining peer-reviewed science, superior comfort, and thoughtful design, the Assisi Loop Lounge expands Zomedica's evidence-based therapeutic portfolio and reinforces Assisi's...
TEL AVIV, Israel, Oct. 23, 2025 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (the "Company" or "SciSparc"), a specialty clinical-stage...
Significant milestones are approaching in drug development; additional digital asset purchases expected Preparation for FDA IND application expected to commence...
Biofrontera Inc. acquires full U.S. rights to Ameluz® and RhodoLED®, including New Drug Application and associated patents, from former parent...
Outstanding measure of efficacy relative to high-risk cancers with limited treatment options CHICAGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- MAIA...
BERKELEY HEIGHTS, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and...
NEW YORK, Oct. 23, 2025 /PRNewswire/ -- BioNxt Solutions Inc. (CSE:BNXT) (OTCQB:BNXTF) (FSE:BXT), a bioscience company developing next-generation drug delivery...
PALO ALTO, CA / ACCESS Newswire / October 23, 2025 / Bioz, Inc., the industry-standard AI citation solution built to...
"The ex-New Jersey Attorney General and former DEA Administrator promised to modernize justice through data. Instead, under her watch, illegal...
The following is a corrected version of the Oct. 21, 2025, press release, MDaudit Spotlights the Vital Role of Health...
Based on a Black Book Research flash survey of 97 HIM leaders conducted at AHIMA 2025 last week. MINNEAPOLIS, MN...